Positive Results from Phase 3 BouNDless Trial of Investigational ND0612 in People with Parkinson ' s Disease Experiencing Motor Fluctuation

JERSEY CITY, N.J., March 18, 2024. Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of results in The Lancet Neurology from the pivotal, Phase 3 BouNDless trial (NCT04006210) evaluating the efficacy, safety and...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials